United States · 
Who invested in Ashvattha Therapeutics?
Ashvattha Therapeutics's investors include Tribe Capital and Sam Altman.
United States · Series B startup
Who invested in Ashvattha Therapeutics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $50MJan 2025
- Investors
- 2
The rounds
- Jan 2025
Everyone who backed them
Sam AltmanAngel1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ashvattha Therapeutics
How much has Ashvattha Therapeutics raised?
Ashvattha Therapeutics has raised $50M across 1 round since 2025.
When did Ashvattha Therapeutics last raise?
Ashvattha Therapeutics's most recent round was a Series B of $50M in Jan 2025.
What was Ashvattha Therapeutics's biggest round?
Its most recent round, $50M in Jan 2025, is also its largest on record.
Who backed Ashvattha Therapeutics first?
Ashvattha Therapeutics's first round on record, in Jan 2025, was backed by Tribe Capital and Sam Altman.
What stage is Ashvattha Therapeutics at?
Ashvattha Therapeutics's latest named round is a Series B, in Jan 2025.
Where is Ashvattha Therapeutics based?
Ashvattha Therapeutics is based in the United States.
Companies like Ashvattha Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.